JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 85 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $149 | +67.4% | 80,336 | 0.0% | 0.00% | – |
Q4 2022 | $89 | -99.9% | 80,336 | +104.2% | 0.00% | – |
Q3 2022 | $93,000 | +57.6% | 39,336 | +100.5% | 0.00% | – |
Q2 2022 | $59,000 | -86.5% | 19,618 | -69.5% | 0.00% | – |
Q1 2022 | $437,000 | +414.1% | 64,309 | +530.9% | 0.00% | – |
Q4 2021 | $85,000 | -94.3% | 10,194 | -94.9% | 0.00% | – |
Q3 2021 | $1,497,000 | +18.4% | 201,494 | +8.4% | 0.00% | – |
Q2 2021 | $1,264,000 | -12.5% | 185,858 | +32.2% | 0.00% | – |
Q1 2021 | $1,444,000 | +96.5% | 140,626 | +33.9% | 0.00% | – |
Q4 2020 | $735,000 | – | 104,996 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 10,230,349 | $63,428,000 | 41.36% |
TRV GP III, LLC | 3,048,780 | $18,902,000 | 9.26% |
Omega Fund Management, LLC | 1,059,930 | $6,572,000 | 1.39% |
Alambic Investment Management, L.P. | 50,622 | $314,000 | 0.13% |
Spark Investment Management LLC | 244,300 | $1,514,000 | 0.07% |
ALGERT GLOBAL LLC | 14,182 | $88,000 | 0.05% |
Redmile Group, LLC | 254,590 | $1,578,000 | 0.05% |
Granahan Investment Management | 125,533 | $778,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 38,602 | $239,000 | 0.02% |
Frontier Wealth Management LLC | 27,099 | $168,000 | 0.02% |